Connor Clark & Lunn Investment Management Ltd. Purchases New Shares in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Crescent Capital BDC, Inc. (NASDAQ:CCAP) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 34,371 shares of the company’s stock, valued at approximately $661,000.

Other institutional investors have also recently modified their holdings of the company. Montag A & Associates Inc. bought a new stake in shares of Crescent Capital BDC during the 4th quarter valued at $35,000. Oppenheimer & Co. Inc. acquired a new position in Crescent Capital BDC in the 4th quarter worth about $261,000. Ieq Capital LLC increased its holdings in Crescent Capital BDC by 2.6% in the 4th quarter. Ieq Capital LLC now owns 22,725 shares of the company’s stock worth $437,000 after purchasing an additional 584 shares in the last quarter. Redhawk Wealth Advisors Inc. acquired a new position in Crescent Capital BDC in the 4th quarter worth about $659,000. Finally, Van ECK Associates Corp increased its holdings in Crescent Capital BDC by 2.3% in the 4th quarter. Van ECK Associates Corp now owns 45,562 shares of the company’s stock worth $876,000 after purchasing an additional 1,006 shares in the last quarter. 49.46% of the stock is currently owned by institutional investors.

Crescent Capital BDC Stock Down 0.6 %

CCAP stock opened at $17.63 on Friday. Crescent Capital BDC, Inc. has a twelve month low of $16.81 and a twelve month high of $20.19. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18. The stock’s 50 day moving average is $18.74 and its 200-day moving average is $18.80. The firm has a market capitalization of $653.40 million, a PE ratio of 8.86 and a beta of 0.82.

Crescent Capital BDC (NASDAQ:CCAP) last issued its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). The business had revenue of $46.40 million for the quarter, compared to analysts’ expectations of $47.27 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. Sell-side analysts expect that Crescent Capital BDC, Inc. will post 2.09 EPS for the current fiscal year.

Crescent Capital BDC Announces Dividend

The company also recently announced a dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were given a $0.05 dividend. The ex-dividend date of this dividend was Friday, February 28th. Crescent Capital BDC’s dividend payout ratio is currently 84.42%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Keefe, Bruyette & Woods increased their price target on Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research note on Monday, November 25th. Wells Fargo & Company cut their price target on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Friday, February 21st. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $19.20.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.